Clinical Trials Logo

Spinal Deformity clinical trials

View clinical trials related to Spinal Deformity.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06020417 Not yet recruiting - Spinal Fusion Clinical Trials

Pedicle Screw Malposition in Spine Arthrodesis Surgeries With O-ARM-guided Navigation

NoHARM
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Background: Throughout the history of spinal deformity there have been continuous advances in the surgical treatment. Although many techniques have been successfully developed despite the anatomy complex, screw placement still remains difficult with a significant risk of misplaced implants. The O-ARM guided Navigation is a scanner that allows imaging of screws intraoperatively and could be a tool to facilitate screw revision and reduce the occurrence of misplaced implants. Methods: This is a prospective and randomized clinical study that will be carried out at the University Hospital of the Federal University of Piaui, which provides exclusive assistance to patients of the Unified Health System (UHS), in northeastern Brazil.

NCT ID: NCT05982808 Not yet recruiting - Spinal Deformity Clinical Trials

CLIF Correction VS. Conventional Correction Strategy for ASD

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The present study intends to: 1)establish a multi-center large-sample randomized controlled trial to explore the technical advantages and surgical indications of the novel surgical technique of CLIF correction for ASD compared with the conventional correction strategy; 2)analyze the postoperative clinical and imaging results, and to explore the related complications and preventive measures; 3) establish 2-year follow-up to further quantify the clinical and radiographical outcomes of CLIF correction.

NCT ID: NCT04610021 Not yet recruiting - Quality of Life Clinical Trials

Prospective i-FactorTM Analysis Fusion Rate and Quality of Life

Start date: March 2021
Phase: N/A
Study type: Interventional

Adult spinal deformity surgery is a complex procedure that involves many risks and complications. Bone grafts and bone substitutes are essential to achieve fusion and manage stability in spinal surgery. Autologous bone has been considered the "gold-standard" for obtaining a spinal fusion. However, the source from which to obtain it is limited. Furthermore, the problems of bone quality in patients with osteoporosis and the morbidity have forced the orthopedic community to seek other options. I-Factor ™ Bone Graft (Cerapedics, Inc., Westminster, CO) is a compound formed by peptide P-15 bound to an anorganic bone mineral of bovine origin that is composed of porous and smooth hydroxyapatite (ABM) particles. In the literature there are no articles which identify bone formation with the i-Factor ™ graft in more than 4 instrumented levels, therefore the development of this study will allow assessing the fusion rate and quality of life of patients, which could lead to an improvement in the management and decision-making of surgical procedures, as well as better control of healthcare spending